Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 75 TWD -4.09% Market Closed
Market Cap: 9B TWD
Have any thoughts about
Formosa Laboratories Inc?
Write Note

Formosa Laboratories Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Formosa Laboratories Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Formosa Laboratories Inc
TWSE:4746
Operating Income
NT$737.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
Y
YungShin Global Holding Corp
TWSE:3705
Operating Income
NT$1.3B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
5%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Income
NT$446.4m
CAGR 3-Years
22%
CAGR 5-Years
4%
CAGR 10-Years
-6%
S
SCI Pharmtech Inc
TWSE:4119
Operating Income
NT$145.3m
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Income
NT$4.5B
CAGR 3-Years
27%
CAGR 5-Years
38%
CAGR 10-Years
55%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Income
NT$1.4B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
15%
No Stocks Found

Formosa Laboratories Inc
Glance View

Market Cap
9B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
128.38 TWD
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Formosa Laboratories Inc's Operating Income?
Operating Income
737.2m TWD

Based on the financial report for Jun 30, 2024, Formosa Laboratories Inc's Operating Income amounts to 737.2m TWD.

What is Formosa Laboratories Inc's Operating Income growth rate?
Operating Income CAGR 10Y
12%

Over the last year, the Operating Income growth was 48%.

Back to Top